Call Us 080-41656200 (Mon-Sat: 10AM-8PM)
Free Shipping above Rs. 1499
Cash On Delivery*

Effects of new onset diabetes and dyslipidemia on the allograft


Marketed By :  LAP LAMBERT Academic Publishing   Sold By :  Kamal Books International  
Delivery in :  10-12 Business Days


Check Your Delivery Options

Rs. 2,675

Availability: In stock

  • Product Description

The principal risk factors for cardiovascular mortality posttransplantation are hyperglycemia, hypertriglyceridemia, obesity, and smoking. We assessed the risk factors for new-onset diabetes and dyslipidemia and their effects on the function and histopathologic changes in the allografts at 1 year posttransplantation. In regard to immunosuppressive therapy, new onset diabetes mellitus was significantly more frequent among patients prescribed tacrolimus, whereas subjects who received cyclosporine A showed a significantly higher incidence of dyslipidemia. In regard to allograft function, a significant difference was noted at year 1 after transplantation. When assessing morphologic changes in the kidney, we observed significantly more frequent interstitial fibrosis/tubular atrophy in all 3 groups compared with normal function patients. Our clinical study suggested that at year 1 after transplantation the allograft function is already impaired in the presence of both medical conditions (diabetes and dyslipidemia). However, in regard to morphology, a single condition (diabetes or dyslipidemia) is sufficient to produce histologic changes in the kidney.

Product Specifications
SKU :COC84388
AuthorBernadett Borda
Number of Pages52
Publishing Year2013-04-02T00:00:00.000
Edition1 st
Book TypeMedicine
Country of ManufactureIndia
Product BrandLAP LAMBERT Academic Publishing
Product Packaging InfoBox
In The Box1 Piece
Product First Available On ClickOnCare.com2015-10-08 00:00:00